d******8
发帖数: 1972 | 1 老牛一直推荐，从6快多就开始买，可惜总是拿不住，要吗是止损出局，要吗是赢点小
钱跑了。进进出出无数次。现在在15.20左右又一次进来，希望FDA能够通过。
FDA时间7/26/12.通过的可能非常大，但也不排除意外。通过后价格在19－22块左右。 |
t******o
发帖数: 6493 | 2 肯定过了
【在 d******8 的大作中提到】
: 老牛一直推荐，从6快多就开始买，可惜总是拿不住，要吗是止损出局，要吗是赢点小
: 钱跑了。进进出出无数次。现在在15.20左右又一次进来，希望FDA能够通过。
: FDA时间7/26/12.通过的可能非常大，但也不排除意外。通过后价格在19－22块左右。
|
c**t
发帖数: 2889 | 3 我打算long，FDA应该没啥问题，之后patent和partnership是个看点，如果FDA和
patent889都搞定了，就会有buyout rumor了。
【在 d******8 的大作中提到】
: 老牛一直推荐，从6快多就开始买，可惜总是拿不住，要吗是止损出局，要吗是赢点小
: 钱跑了。进进出出无数次。现在在15.20左右又一次进来，希望FDA能够通过。
: FDA时间7/26/12.通过的可能非常大，但也不排除意外。通过后价格在19－22块左右。
|
t*******c
发帖数: 288 | |
h****2
发帖数: 40 | |
d******8
发帖数: 1972 | 6 How To Trade Amarin After The FDA Decision
http://seekingalpha.com/article/740071-how-to-trade-amarin-afte
Assuming FDA approval, which is widely expected, here are my scenarios for
trading around AMRN post approval:
Scenario 1) FDA approval with NCE. I would expect shares to open at $21-23.
Sell half and hold the rest. NCE would likely lead to an eventual buyout by
a large pharmaceutical company.
Scenario 2) FDA approval; without NCE. I would expect shares to open at $18-
20. Traders should be selling all shares immediately. I would likely
initiate a short position on the open, expecting shares to possibly be down
on the day by the close.
Scenario 3) FDA approval, no decision on NCE. I would expect shares to open
$19-21. Trader will likely sell all their shares and step to the sidelines.
Shares will likely drift lower, but still be up on the day.
If a partnership is announced alongside the FDA approval, expect shares to
trade higher than my stated ranges. However, shares will still sell off as
investors and traders hoping for an immediate buyout see their hopes dashed
by a partnership. Investors and trader should take notice that AMRN will
likely fall in the coming days post-FDA approval as most stocks do. After
Arena Pharmaceuticals received FDA approval, investors saw their shares fall
31% in just 4 days after the opening trade of $13.50/share. Also, VVUS fell
28% in the 3 days following FDA approval after gapping up above $30/share
on the opening trade. As soon as the catalyst ends for a stock, traders
leave shares and head to the sidelines |
N*******0
发帖数: 1392 | 7 竞猜，明天AMRN开盘多少？
.
by
18-
down
【在 d******8 的大作中提到】
: How To Trade Amarin After The FDA Decision
: http://seekingalpha.com/article/740071-how-to-trade-amarin-afte
: Assuming FDA approval, which is widely expected, here are my scenarios for
: trading around AMRN post approval:
: Scenario 1) FDA approval with NCE. I would expect shares to open at $21-23.
: Sell half and hold the rest. NCE would likely lead to an eventual buyout by
: a large pharmaceutical company.
: Scenario 2) FDA approval; without NCE. I would expect shares to open at $18-
: 20. Traders should be selling all shares immediately. I would likely
: initiate a short position on the open, expecting shares to possibly be down
|
m*******y
发帖数: 18 | |
t******o
发帖数: 6493 | |
p******8
发帖数: 313 | 10 seems like no decision on NCE |
A**********r
发帖数: 53 | 11 AMRN过了FDA，跌了10%
HZNP也过了，跌了20%
这尼玛还不如过以前了，为什么啊？
【在 p******8 的大作中提到】
: seems like no decision on NCE
|
